In this article, posted on Nutraingredients-USA, Dennis Raglin discusses FDA’s new actions against dietary supplements containing ingredients with potential health risks to the public. This action follows the release of an August 11, 2016 revised draft guidance designed to improve the new dietary drug ingredient (NDI) premarket notification process, “Dietary Supplements: New Dietary Ingredient Notifications and Related Issues.” These…